Skip To Main Content
Byington RP on Muck Rack

Byington RP

As seen in: BMJ Open Diabetes Research & Care, The New England Journal of Medicine, The Lancet, Canadian Medical Association Journal, Annals of Internal Medicine, Diabetes Care Magazine, Diabetes Magazine, Atherosclerosis, Clinical Therapeutics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Byington

Contact Byington, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recommendations on screening for type 2 diabetes in adults

|
By Gerstein HC, Miller ME, Byington RP
| Canadian Medical Association Journal Verified
Recommendations A summary of the recommendations for clinicians and policy-makers is shown in Box 1. The recommendations have been graded according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, which is summarized in Box 2.15 Box 1: Recommendations are presented for screening asymptomatic adults for type 2 diabetes. They do not apply to people with symptoms of diabetes or those at risk of type 1 diabetes.
Open in Who Shared Issue with article?

Type 2 Diabetes | Annals of Internal Medicine

|
By Byington RP, Neda Laiteerapong
| Annals of Internal Medicine Verified
Can't sign in? Forgot your password? Enter your email address below and we will send you the reset instructions If the address matches an existing account you will receive an email with instructions to reset your password. Request Username Can't sign in? Forgot your username?
Open in Who Shared Issue with article?

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians

|
By Byington RP
| Annals of Internal Medicine Verified
Discussion SGLT2 inhibitors and GLP1 agonists reduce overall mortality compared with usual care and insulin in middle- aged, previously treated adults with T2DM. GLP1 agonists also reduce mortality compared with DPP4 inhibitors. SGLT2 inhibitors and GLP1 agonists reduce MACE compared with usual care, but neither drug reduces MI.
Open in Who Shared Issue with article?
See all 20 articles